enginzyme

Отрасль

Косметика, Оборудование для биопроизводства, Промышленная химия

Темы

Ферменты и биокатализ, Платформы синтетической биологии и биопроизводство

Роль

Производитель — “…ce traditional fossil-based manufacturing methods [1][4][3]. The company is privately held and recently closed…”

Почему это биоэкономика

EnginZyme разрабатывает бесклеточную ферментную платформу для химического производства и биокатализа.

Как найдена

Novonesis; AB Enzymes; [Rubric] Finland · lipase-oils; [Rubric] Norway · lipase-oils

Пока не указана поставщиком в решениях с доказательствами.

• 2026-09 Последний статус: В сентябре 2026 г. компания привлекла 75 млн шведских крон в новом раунде, чтобы перейти от НИОКР к коммерческой стратегии. ↗ ↗ ↗
• 2026-09-23 Enginzyme Raises SEK 75 Million to Advance Its Commercial Biomanufacturing Strategy - BioSpace
  Enginzyme has closed a SEK 75 million equity round, signaling a strategic shift from R&D toward commercial biomanufacturing in personal care, food, and pharmaceutical applications. The funding brings in new shareholders and board members to support its enzyme …
• 2026-09-23 Enginzyme AB Closes New Equity Round Raising SEK 75 Million — TradingView News
  Enginzyme AB has closed a new equity round, raising SEK 75 million, signaling investor confidence and potential growth funding for the company.
• 2026-09-22 SEK 75 million equity round bolsters enginzyme's commercial strategy — Sofinnova Partners
  Enginzyme has closed a SEK 75 million equity round, signaling a pivot from R&D to a commercially driven strategy with new shareholders and board members to accelerate biomanufacturing solutions for personal care, food, and pharma industries.
• 2026-09-23 Enginzyme Raises SEK 75 Million to Advance Its Commercial Biomanufacturing Strategy | Business Wire
  Enginzyme has raised SEK 75 million in a new equity round, signaling a strategic shift from R&D toward a commercially driven biomanufacturing agenda. The funding, including new shareholders and board members, supports its goal of delivering cost-efficient, …
• 2026-10-02 Enginzyme Raises SEK 75 Million To Advance Commercial Biomanufacturing Strategy
  Enginzyme has raised SEK 75 million to shift from R&D toward commercial biomanufacturing, expanding adoption of its enzyme-based, cell-free manufacturing technology for personal care, food, and pharma, with new investors joining the board to support scalable, …
• 2026-09-23 EnginZyme raises US$9.07M to shift from R&D to commercial biomanufacturing | Dealroom News
  EnginZyme has closed a US$9.07M Series C to pivot from R&D toward commercial biomanufacturing, strengthening its leadership with new investors including Lotus One Investment and Valquest Partners Europe. The funding supports scaling enzyme-based, non-chemical …

Владельцы и инвесторы 5

Похожие компании

C3 Biotech · GFBiochemicals · DAB.bio · Green Biologics Ltd. · NorFalk · Biochemtex · Cascat GmbH · Arsenale Bioyards